Skip to main content Back to Top

4/24/2001

Pulmozyme Ampuls Recalled Because of Defect

Cheryl A. Thompson

Genentech Inc. is recalling Pulmozyme oral inhalation solution lot N9700A because some of the ampules have a tiny puncture and could leak.

The company said the ampules were damaged during manufacture. A similar problem occurred 13 months ago.

Pulmozyme, or dornase alfa, is used in the treatment of cystic fibrosis. The drug solution does not contain a preservative.